FENBENDAZOLE+ 444MG LAB TESTED| PURITY)99% 90 CAPSULES

Live / Applied — Final refusal mailed (as of 05 Nov 2026)

Now

Refused — a final office action was mailed 05 Nov 2026.

A response is due by 05 Feb 2027; with no response the application is abandoned.

What this means for you

Not registered yet, but its 29 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
99417673
Mark type
Design + words
Filed
29 Sept 2025
Attorney of record
Baruch Gottesman

Goods and services

  • Class 005 — Pharmaceuticals: Probiotic supplements; Vitamin supplements; Food supplements; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of viral diseases; Prebiotic supplements; Nutritional supplements; Mixed antibiotic preparations; Pharmaceutical products for the treatment of viral diseases; Biological preparations for the prevention and treatment of broad spectrum warm, parasitic infections, allergic reactions, viral infections, viral disease

Owner

Prosecution history

  • 05 Nov 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
  • 05 Nov 2026 — FINAL REFUSAL E-MAILED
  • 05 Nov 2026 — FINAL REFUSAL WRITTEN
  • 10 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 10 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 10 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 27 Jul 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 27 Jul 2026 — NON-FINAL ACTION E-MAILED
  • 27 Jul 2026 — NON-FINAL ACTION WRITTEN
  • 09 Jul 2026 — ASSIGNED TO EXAMINER
  • 23 Feb 2026 — ASSIGNED TO EXAMINER
  • 20 Feb 2026 — ASSIGNED TO EXAMINER
  • 19 Feb 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
  • 19 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 29 Sept 2025 — APPLICATION FILING RECEIPT MAILED

View this trademark record on Rightsy